Market Place
Sourcing Support
Osmotica Pharma`s Generics Carbamazepine Receives Approval in US
22 Oct 2024 //
FDA
Osmotica Pharma Announces Corporate Name Change to RVL Pharmaceuticals; and more
19 Jan 2022 //
GLOBENEWSWIRE
Osmotica Pharmaceuticals plc to Present at H.C. Wainwright Bioconnect Conference
20 Dec 2021 //
GLOBENEWSWIRE
Osmotica Pharmaceuticals plc Reports Third Quarter 2021 Results
15 Nov 2021 //
GLOBENEWSWIRE
Osmotica Pharmaceuticals plc to Present at Jefferies London VHC
15 Nov 2021 //
GLOBENEWSWIRE
Osmotica Announces Closing of $35 Million Underwritten Public Offering
13 Oct 2021 //
GLOBENEWSWIRE
Osmotica Pharmaceuticals plc Announces Proposed Underwritten Public Offering
06 Oct 2021 //
GLOBENEWSWIRE
Osmotica Pharmaceuticals Announces Pricing of $35 M
06 Oct 2021 //
GLOBENEWSWIRE
Osmotica Pharma to Present at Cantor Virtual Global Healthcare Conference 2021
22 Sep 2021 //
GLOBENEWSWIRE
Osmotica Pharmaceuticals Closes Sale of Legacy Business to Alora Pharmaceuticals
30 Aug 2021 //
GLOBENEWSWIRE
Osmotica Pharmaceuticals plc Reports Second Quarter 2021 Results
16 Aug 2021 //
GLOBENEWSWIRE
Osmotica to Present at H.C. Wainwright Ophthalmology Conference
13 Aug 2021 //
GLOBENEWS WIRE
Osmotica Subsidiary RVL Pharmaceuticals Strengthens and Expands Leadership Team
30 Jun 2021 //
GLOBENEWSWIRE
Osmotica Announces Conclusion of Strategic Process to Alora Pharma
25 Jun 2021 //
GLOBENEWSWIRE
Osmotica Announces Agreement to Settle Patent Litigation with Adamas
01 Dec 2020 //
GLOBENEWSWIRE
Santen & RVL an Osmotica Company, Enter into an Exclusive License Agreement
28 Jul 2020 //
GLOBENEWSWIRE
Osmotica Pharma Announces FDA User Fee Goal Date of December 29, 2020
20 Jul 2020 //
GLOBENEWSWIRE
Osmotica Announces Proposed Public Offering of Ordinary Shares
13 Jul 2020 //
GLOBENEWSWIRE
Osmotica Pharmaceuticals plc Receives FDA Approval for Upneeq™
09 Jul 2020 //
GLOBENEWSWIRE
Osmotica Pharmaceuticals US LLC Submits Amended NDA for Arbaclofen
30 Jun 2020 //
GLOBENEWSWIRE
Osmotica Pharma Announces Result of Proposal 3 at Annual General Meeting
27 May 2020 //
PRNEWSWIRE
Osmotica Announces Pricing of Public Offering of Ordinary Shares
08 Jan 2020 //
BENZINKA
Osmotica Announces Pricing of Public Offering of Ordinary Shares
07 Jan 2020 //
BENZINKA
Osmotica Announces Pricing of Public Offering of Ordinary Shares
07 Jan 2020 //
BENZINKA
Osmotica Announces Proposed Public Offering of Ordinary Shares
06 Jan 2020 //
BENZINGA
Osmotica Pharmaceuticals plc Announces Pricing of Initial Public Offering
17 Oct 2018 //
BIOSPACE
Osmotica Pharmaceuticals Files To Raise Capital In U.S. IPO
19 Sep 2018 //
SEEKING ALPHA
Enforcement Report - Week of March 14, 2018
14 Mar 2018 //
FDA
Gocovri™Osmolex Er™(Amantadine Hcl): Osmotica Pharmaceutical US v. Adamas Pharm
16 Feb 2018 //
PATENT LITIGATION
Enforcement Report - Week of December 27, 2017
27 Dec 2017 //
FDA
Osmotica’s Generic Methylphenidate Hydrochloride Receives Approval In US
31 Jul 2017 //
FDA
Vertical Pharmaceuticals, Inc Receives FDA Warning Letter
17 May 2017 //
FDA
Osmotica`s Generic Hydromorphone Hydrochloride Approved in USA To Treat Pain
07 Jul 2016 //
FDA
Vertical / Trigen Holdings, LLC and Osmotica Holdings Corp Complete Combination
04 Feb 2016 //
PRNEWSWIRE
Vertical/Trigen Holdings,Osmotica Holding to Combine,Creating Pharma Company
04 Dec 2015 //
PR NEWS WIRE
